AI Breast Cancer Risk Prediction Tool Receives FDA Clearance For Faster Insights
AI is moving deeper into breast cancer care, and a newly cleared risk prediction tool now gives physicians a faster way to estimate the chance of distant metastasis after surgery. The U.S. Food and Drug Administration clearance for ArteraAI Breast marks a notable step for digital pathology, where scanned tumor slides and clinical data can … Read more